Concepedia

Samuel Ofori

SO

Statistics

Publications

10

Citations

691

H-Index

10

Active since

2019

Affiliations

University of Kentucky(Current)

Markey Cancer Center

Oberlin College

Samuel Ofori is an author at University of Kentucky specializing in medicinal chemistry, molecular oncology, and drug discovery.

Publications per year

2019–2023

10

Publications

10

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Anticancer gold(<scp>iii</scp>)-bisphosphine complex alters the mitochondrial electron transport chain to induce <i>in vivo</i> tumor inhibition

Jong Hyun Kim, Samuel Ofori, Sean Parkin et al. · Chemical Science · 2021 · 52 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Gold(III)-P-chirogenic complex induces mitochondrial dysfunction in triple-negative breast cancer

Chibuzor Olelewe, Jong Hyun Kim, Samuel Ofori et al. · iScience · 2022 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Small-Molecule Poly(ADP-ribose) Polymerase and PD-L1 Inhibitor Conjugates as Dual-Action Anticancer Agents

Samuel Ofori, Samuel G. Awuah · ACS Omega · 2019 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Water‐Soluble Gold(III)–Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells

Jong Hyun Kim, Samuel Ofori, R. Tyler Mertens et al. · ChemMedChem · 2021 · 33 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–5 of 10